Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment
Yunan Gu(Hunan University of Traditional Chinese Medicine), Ya Li(Hunan University of Traditional Chinese Medicine), Xiang Gu(Hunan University of Traditional Chinese Medicine), Juan Qin(Hunan University of Traditional Chinese Medicine), Yuxin Wu(Hunan University of Traditional Chinese Medicine), Lixin Du(Hunan University of Traditional Chinese Medicine), Zhihua Guo(Hunan University of Traditional Chinese Medicine)
Cited by 13
Related Papers
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
|Ageing Research Reviews|2024|69
Hydrophilicity-Dependent Distinct Frictional Behaviors of Different Modified MXene Nanosheets
|The Journal of Physical Chemistry C|2020|65
Upregulation of microRNA‑206 induces apoptosis of vascular smooth muscle cells and decreases risk of atherosclerosis through modulating FOXP1
|Experimental and Therapeutic Medicine|2017|30
Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway
|Molecules|2023|17
Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
|Scientific Reports|2023|16